James P. Boylan - 11 Feb 2025 Form 4 Insider Report for Compass Therapeutics, Inc. (CMPX)

Role
Director
Signature
/s/ Neil Lerner, as attorney-in-fact
Issuer symbol
CMPX
Transactions as of
11 Feb 2025
Net transactions value
$0
Form type
4
Filing time
13 Feb 2025, 17:05:34 UTC
Previous filing
10 Oct 2024
Next filing
12 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMPX Stock Option (Right to Buy) Award $0 +40,000 $0.000000 40,000 11 Feb 2025 Common Stock 40,000 $3.65 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest over 48 substantially equal monthly installments starting March 11, 2025.
F2 The Reporting Person is a member of Enavate Sciences, LP ("Enavate"). Pursuant to an agreement with Enavate, the Reporting Person is obligated to transfer any securities issued under any stock options or other awards, or the economic benefit thereof, to Enavate, which will in turn ensure that such securities or economic benefits are provided to Enavate.